Skin diseases associated with Malassezia species

Journal of the American Academy of Dermatology

Volumn 51, Issue 5, 2004, Pages 785-798

  Gupta, Aditya K ^a,b   Batra, Roma ^a   Bluhm, Robyn ^a   Boekhout, Teun ^a   Dawson Jr , Thomas L ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Ontario Canada N5X 2P1 ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BENZYLAMINE DERIVATIVE; BIFONAZOLE; BUTENAFINE; CICLOPIROXOLAMINE; CLOTRIMAZOLE; CORTICOSTEROID; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; IMIDAZOLE; IMMUNOGLOBULIN G; ITRACONAZOLE; KERATOLYTIC AGENT; KETOCONAZOLE; METRONIDAZOLE; MICONAZOLE; PIMECROLIMUS; PYRIDONE DERIVATIVE; PYRROLE DERIVATIVE; SALICYLIC ACID; SELENIUM SULFIDE; STEROID; SULCONAZOLE; TACROLIMUS; TERBINAFINE;

ATOPIC DERMATITIS; DANDRUFF; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FOLLICULITIS; HUMAN; IMMUNOLOGY; LIPID COMPOSITION; MALASSEZIA; MYCOLOGY; MYCOSIS; PARKINSON DISEASE; PATHOGENESIS; PITYROSPORUM OVALE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SEBORRHEIC DERMATITIS; SKIN DISEASE; SPINE INJURY; TINEA VERSICOLOR;

DERMATITIS, ATOPIC; DERMATITIS, SEBORRHEIC; DERMATOMYCOSES; FOLLICULITIS; HUMANS; IMMUNOCOMPROMISED HOST; MALASSEZIA; PSORIASIS; SCALP DERMATOSES; TINEA VERSICOLOR;

EID: 8744270485     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.12.034     Document Type: Review

References (183)

1. Borelli D. [Pityriasis versicolor due to Malassezia ovalis]. Mycopathologia. 89:1985;147-153. Spanish
2. Faergemann J., Fredriksson T. Experimental infections in rabbits and humans with Pityrosporum orbiculare and P ovale. J Invest Dermatol. 77:1981;314-318
3. Guého E., Midgley G., Guillot J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek. 69:1996;337-355
4. Sugita T., Takashima M., Shinoda T., Suto H., Unno T., Tsuboi R., et al. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J Clin Microbiol. 40:2002;1363-1367
5. Nell A., James S.A., Bond C.J., Hunt B., Herrtage M.E. Identification and distribution of a novel Malassezia species yeast on normal equine skin. Vet Rec. 150:2002;395-398
6. Gupta A.K., Kohli Y., Summerbell R.C., Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol. 39:2001;243-251
7. Nakabayashi A., Sei Y., Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol. 38:2000;337-341
8. Gupta A.K., Kohli Y., Faergemann J., Summerbell R.C. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med Mycol. 39:2001;199-206
9. Gemmer C.M., DeAngelis Y.M., Theelen B., Boekhout T., Dawson J.T. Jr. Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol. 40:2002;3350-3357
10. Gupta A.K., Kohli Y., Summerbell R.C. Molecular differentiation of seven Malassezia species. J Clin Microbiol. 38:2000;1869-1875
11. Theelen B., Silvestri M., Guého E., Van Belkum A., Boekhout T. Identification and typing of Malassezia yeasts using amplified fragment length polymorphism (AFLP), random amplified polymorphic DNA (RAPD) and denaturing gradient gel electrophoresis (DGGE). FEMS Yeast Res. 1:2001;79-86
12. Boekhout T., Kamp M., Gueho E. Molecular typing of Malassezia species with PFGE and RAPD. Med Mycol. 36:1998;365-372
13. Chang H.J., Miller H.L., Watkins N., Arduino M.J., Ashford D.A., Midgley G., et al. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs. N Engl J Med. 338:1998;706-711
14. Mickelsen P.A., Viano-Paulson M.C., Stevens D.A., Diaz P.S. Clinical and microbiological features of infection with Malassezia pachydermatis in high-risk infants. J Infect Dis. 157:1988;1163-1168
15. Van Belkum A., Boekhout T., Bosboom R. Monitoring spread of Malassezia infections in a neonatal intensive care unit by PCR-mediated genetic typing. J Clin Microbiol. 32:1994;2528-2532
16. Brooks R., Brown L. Systemic infection with Malassezia furfur in an adult receiving long-term hyperalimentation therapy. J Infect Dis. 156:1987;410-411
17. Surmont I., Gavilanes A., Vandepitte J., Devlieger H., Eggermont E. Malassezia furfur fungaemia in infants receiving intravenous lipid emulsions. A rarity or just underestimated? Eur J Pediatr. 148:1989;435-438
18. Weiss S.J., Schoch P.E., Cunha B.A. Malassezia furfur fungemia associated with central venous catheter lipid emulsion infusion. Heart Lung. 20:1991;87-90
19. Ashbee H.R., Evans E.G. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 15:2002;21-57
20. Warner R.R., Schwartz J.R., Boissy Y., Dawson T.L. Jr. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol. 45:2001;897-903
21. Farthing C.F., Staughton R.C.D., Rowland Payne C.M.E. Skin disease in homosexual patients with Acquired Immune Deficiency Syndrome (AIDS) and lesser forms of human T cell Leukaemia Virus (HTLV III) disease. Clin Exp Dermatol. 10:1985;3-12
22. Smith K.J., Skelton H.G., Yeager J., Ledsky R., McCarthy W., Baxter D., et al. Cutaneous findings in HIV-1 positive patients: a 42-month prospective study. J Am Acad Dermatol. 31:1994;746-754
23. Bulmer A.C., Bulmer G.S. The antifungal action of dandruff shampoos. Mycopathologia. 147:1999;63-65
24. Kligman A.M. Perspectives and problems in cutaneous gerontology. J Invest Dermatol. 73:1979;39-46
25. McGrath J., Murphy G.M. The control of seborrhoeic dermatitis and dandruff by antipityrosporal drugs. Drugs. 41:1991;178-184
26. Pierard-Franchimont C., Hermanns J.F., Degreef H., Pierard G.E. From axioms to new insights into dandruff. Dermatology. 200:2000;93-98
27. Danby F.W., Maddin W.S., Margesson L.J., Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 29:1993;1008-1012
28. Priestley G.C., Savin J.A. The microbiology of dandruff. Br J Dermatol. 94:1976;469-471
29. Faergemann J. Seborrheic dermatits (dandruff). 2000;Marcel Dekker Inc, New York. p. 197-202
30. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol. 111:1984;235-242
31. Piérard G.E., Arrese J.E., Piérard-Franchimont C., De Doncker P. Prolonged effects of antidandruff shampoos-time to recurrence of Malassezia ovalis colonization of skin. Int J Cosm Sci. 19:1997;111-117
32. Wilson C.L., Walshe M. Incidence of seborrhoeic dermatitis in spinal injury patients. Br J Dermatol. 119:1988;s48
33. Cotterill J.A., Cunliffe W.J., Williamson B., Bulusu L. Age and sex variation in skin surface lipid composition and sebum excretion rate. Br J Dermatol. 87:1972;333-340
34. Ramasastry P., Downing D.T., Pochi P.E., Strauss J.S. Chemical composition of human skin surface lipids from birth to puberty. J Invest Dermatol. 54:1970;139-144
35. Mayser P., Pape B. Decreased susceptibility of Malassezia furfur to UV light by synthesis of tryptophane derivatives. Antonie Van Leeuwenhoek. 73:1998;315-319
36. Mayser P., Schafer U., Kramer H.J., Irlinger B., Steglich W. Pityriacitrin-an ultraviolet-absorbing indole alkaloid from the yeast Malassezia furfur. Arch Dermatol Res. 294:2002;131-134
37. Burton J.L., Pye R.J. Seborrhoea is not a feature of seborrhoeic dermatitis. Br Med J. 286:1983;1169-1170
38. MacKee G.M., Lewis G.M. Dandruff and seborrhea: I. Flora of "normal" and diseased scalps. J Invest Dermatol. 1:1938;131-139
39. Sabouraud R. Maladies du cuir chevelu. II. Les maladies desquamatives. 1904;Masson et cie, Paris
40. McGinley K.J., Leyden J.J., Marples R.R., Kligman A.M. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol. 64:1975;401-405
41. Bergbrant I.M., Faergemann J. Seborrhoeic dermatitis and Pityrosporum ovale: a cultural and immunological study. Acta Derm Venereol. 69:1989;332-335
42. Parry M.E., Sharpe G.R. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol. 139:1998;254-263
43. Midgley G., Hay R.J. Serological responses to Pityrosporum (Malassezia) in seborrhoeic dermatitis demonstrated by ELISA and Western blotting. Bull Soc Fr Mycol Med. 17:1988;267-276
44. Midgley G. The lipophilic yeasts: state of the art and prospects. Med Mycol. 38:2000;9-16
45. Troller J.A. Model system for the investigation of dandruff. J Soc Cosm Chem. 22:1971;187-198
46. Binder R.L., Jonelis F.J. Seborrheic dermatitis in neuroleptic-induced parkinsonism. Arch Dermatol. 119:1983;473-475
47. Faergemann J., Fredriksson T. Tinea versicolor with regard to seborrheic dermatitis: an epidemiological investigation. Arch Dermatol. 115:1979;966-968
48. Riciputo R.M., Oliveri S., Micali G., Sapuppo A. Phospholipase activity in Malassezia furfur pathogenic strains. Mycoses. 39:1996;233-235
49. Gueho E., Faergemann J., Lyman C., Anaissie E.J. Malassezia and Trichosporon: two emerging pathogenic basidiomycetous yeast-like fungi. J Med Vet Mycol. 32:1994;367-378
50. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 1:2000;75-80
51. Hay R.J., Graham-Brown R.A. Dandruff and seborrhoeic dermatitis: causes and management. Clin Exp Dermatol. 22:1997;3-6
52. Watanabe S., Kano R., Sato H., Nakamura Y., Hasegawa A. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol. 116:2001;769-773
53. Crespo Erchiga V., Ojeda Martos A., Vera Casano A., Crespo Erchiga A., Sanchez Fajardo F., Guého E. Mycology of pityriasis versicolor. J Mycol Med. 9:1999;143-148
54. Sandström M.H., Bartosik J., Bäck O., Scheynius A., Särnhult T., Tengvall Linder M., et al. The prevalence of the Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. J Eur Acad Dermatol Venereol. 15:2001;104-274
55. Kim S.C., Kim H.U. The distribution of Malassezia species on the normal human skin according to body region. Korean J Med Mycol. 5:2000;120-128
56. Gaitanis G., Velegraki A., Frangoulis E., Mitroussia A., Tsigonia A., Tzimogianni A., et al. Identification of Malassezia species from patient skin scales by PCR-RFLP. Clin Microbiol Infect. 8:2002;162-173
57. Sugita T., Suto H., Unno T., Tsuboi R., Ogawa H., Shinoda T., et al. Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J Clin Microbiol. 39:2001;3486-3490
58. Michalowski R., Rodziewicz H. Pityriasis versicolor in children. Br J Dermatol. 75:1963;397-400
59. Terragni L., Lasagni A., Oriani A., Gelmetti C. Pityriasis versicolor in the pediatric age. Pediatr Dermatol. 8:1991;9-12
60. Congly H. Pityriasis versicolor in a 3-month-old boy. Can Med Assoc J. 130:1984;844-845
61. Wyre H.W. Jr., Johnson W.T. Neonatal pityriasis versicolor. Arch Dermatol. 117:1981;752-753
62. Stein D.H. Superficial fungal infections. Pediatr Clin North Am. 30:1983;545-561
63. Borelli D., Jacobs P.H., Nall L. Tinea versicolor: epidemiologic, clinical, and therapeutic aspects. J Am Acad Dermatol. 25:1991;300-305
64. Burke R.C. Tinea versicolor: susceptibility factors and experimental infection in human beings. J Invest Dermatol. 36:1961;389-402
65. Faergemann J., Bernander S. Tinea versicolor and Pityrosporum orbiculare: a mycological investigation. Sabouraudia. 17:1979;171-179
66. Aste N., Pau M., Aste N., Biggio P. Case report. Pityriasis versicolor mimicking pityriasis rotunda. Mycoses. 45:2002;126-128
67. Desruelles F., Gari-Toussaint M., Lacour J.P., Marty P., Le Fichoux Y., Ortonne J.P. Tinea versicolor mimicking pityriasis rotunda. Int J Dermatol. 38:1999;948-949
68. Ena P., Siddi G.M. Pityriasis versicolor resembling pityriasis rotunda. J Eur Acad Dermatol Venereol. 16:2002;85-87
69. Glazer S.D., Zugerman C. Tinea versicolor of the face. Cutis. 26:1980;87
70. El Gothamy Z., Ghozzi M. Tinea versicolor of the scalp. Int J Dermatol. 34:1995;533-534
71. Goncalves A.P. Unusual locations of pityriasis versicolor with particular reference to scalp lesion. Dermatol Trop. 2:1963;211-216
72. Anthony J.L., Schosser R.H., Gross D.J. Unilateral areolar and periareolar tinea versicolor. Int J Dermatol. 30:1991;600
73. Blumenthal H.L. Tinea versicolor of the penis. Arch Dermatol. 103:1971;461-462
74. Payle B., Serrano L., Bieley H.C., Reyes B.A. Albert's solution versus potassium hydroxide solution in the diagnosis of tinea versicolor. Int J Dermatol. 33:1994;182-183
75. McGinley K.J., Lantis L.R., Marples R.R. Microbiology of tinea versicolor. Arch Dermatol. 102:1970;168-171
76. Savin R. Diagnosis and treatment of tinea versicolor. J Fam Pract. 43:1996;127-132
77. Mayser P., Pickel M., Haze P., Erdmann F., Papavassilis C., Schmidt R. Different utilization of neutral lipids by Malassezia furfur and Malassezia sympodialis. Med Mycol. 36:1998;7-14
78. Weiss R., Raabe P., Mayser P. Yeasts of the genus Malassezia: taxonomic classification and significance in (veterinary and) clinical medicine. [in German] Mycoses. 43:2000;69-72
79. Crespo E.V., Ojeda M.A., Vera C.A., Crespo E.A., Sanchez F.F. Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol. 143:2000;799-803
80. Back O., Faergemann J., Hornqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 12:1985;56-61
81. Katoh T., Irimajiri J. Pityriasis versicolor and Malassezia folliculitis. Nippon Ishinkin Gakkai Zasshi. 40:1999;69-71
82. Leeming J.P., Holland K.T., Cunliffe W.J. The microbial ecology of pilosebaceous units isolated from human skin. J Gen Microbiol. 130:1984;803-807
83. Jacinto-Jamora S., Tamesis J., Katigbak M.L. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence, and management. J Am Acad Dermatol. 24:1991;693-696
84. Back O., Scheynius A., Johansson S.G. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res. 287:1995;448-451
85. Gueho E., Boekhout T., Ashbee H.R., Guillot J., Van Belkum A., Faergemann J. The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol. 36:1998;220-229
86. Faergemann J., Johansson S., Back O., Scheynius A. An immunologic and cultural study of Pityrosporum folliculitis. J Am Acad Dermatol. 14:1986;429-433
87. Lim K.B., Giam Y.C., Tan T. The epidemiology of Malassezia (Pityrosporum) folliculitis in Singapore. Int J Dermatol. 26:1987;438-441
88. Sina B., Kauffman C.L., Samorodin C.S. Intrafollicular mucin deposits in Pityrosporum folliculitis. J Am Acad Dermatol. 32:1995;807-809
89. Faergemann J., Bergbrant I.M., Dohse M., Scott A., Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol. 144:2001;549-556
90. Potter B.S., Burgoon C.F. Jr., Johnson W.C. Pityrosporum folliculitis: report of seven cases and review of the Pityrosporum organism relative to cutaneous disease. Arch Dermatol. 107:1973;388-391
91. Hill M.K., Goodfield J.D., Rodgers F.G., Crowley J.L., Saihan E.M. Skin surface electron microscopy in Pityrosporum folliculitis: the role of follicular occlusion in disease and the response to oral ketoconazole. Arch Dermatol. 126:1990;181-184
92. Bufill J.A., Lum L.G., Caya J.G., Chitambar C.R., Ritch P.S., Anderson T., et al. Pityrosporum folliculitis after bone marrow transplantation: clinical observations in five patients. Ann Intern Med. 108:1988;560-563
93. Rhie S., Turcios R., Buckley H., Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant. 19:2000;215-219
94. Yohn J.J., Lucas J., Camisa C. Malassezia folliculitis in immunocompromised patients. Cutis. 35:1985;536-538
95. Fearfield L.A., Rowe A., Francis N., Bunker C.B., Staughton R.C. Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. Br J Dermatol. 141:1999;3-11
96. Ferrandiz C., Ribera M., Barranco J.C., Clotet B., Lorenzo J.C. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Int J Dermatol. 31:1992;193-195
97. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev. 15:2002;545-563
98. Williams H.C., Burney P.G.J., Pembroke A.C., Hay R.J. The UK Working Party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol. 131:1994;406-416
99. Williams H.C. Epidemiology of atopic dermatitis. Clin Exp Dermatol. 5:2000;522-529
100. Thestrup-Pedersen K. The incidence and pathophysiology of atopic dermatitis. J Eur Acad Dermatol Venereol. 7:1996;S3-S7
101. Broberg A., Faergemann J., Johansson S., Johansson S.G., Strannegard I.L., Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol. 72:1992;187-192
102. Clemmensen O.J., Hjorth N. Treatment of atopic dermatitis of the head and neck with ketoconazole in patients with type I sensitivity to P orbiculare. Semin Dermatol. 2:1983;26-29
103. Doekes G., van Ieperen-van Dijk A.G. Allergens of Pityrosporum ovale and Candida albicans. I. Cross-reactivity of IgE-binding components. Allergy. 48:1993;394-400
104. Devos S.A., van der Valk P.G. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis. Allergy. 55:2000;1056-1058
105. Faergemann J. Pityrosporum species as a cause of allergy and infection. Allergy. 54:1999;413-419
106. Huang X., Johansson S.G., Zargari A., Nordvall S.L. Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans. Allergy. 50:1995;648-656
107. Jensen-Jarolim E., Poulsen L.K., With H., Kieffer M., Ottevanger V., Stahl S.P. Atopic dermatitis of the face, scalp, and neck: type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol. 89:1992;44-51
108. Johansson C., Sandstrom M.H., Bartosik J., Sarnhult T., Christiansen J., Zargari A., et al. Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J Dermatol. 148:2003;479-488
109. Kroger S., Neuber K., Gruseck E., Ring J., Abeck D. Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema. Acta Derm Venereol. 75:1995;357-360
110. Rokugo M., Tagami H., Usuba Y., Tomita Y. Contact sensitivity to Pityrosporum ovale in patients with atopic dermatitis. Arch Dermatol. 126:1990;627-632
111. Savolainen J., Lintu P., Kosonen J., Kortekangas-Savolainen O., Viander M., Pene J., et al. Pityrosporum and Candida specific and non-specific humoral, cellular and cytokine responses in atopic dermatitis patients. Clin Exp Allergy. 31:2001;125-134
112. Scalabrin D.M., Bavbek S., Perzanowski M.S., Wilson B.B., Platts-Mills T.A., Wheatley L.M. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol. 104:1999;1273-1279
113. Waersted A., Hjorth N. Pityrosporum orbiculare-a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol Suppl (Stockh). 114:1985;146-148
114. Back O., Bartosik J. Systemic ketoconazole for yeast allergic patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 15:2001;34-38
115. Kieffer M., Bergbrant I.M., Faergemann J., Jemec G.B., Ottevanger V., Stahl S.P., et al. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol. 22:1990;739-742
116. Tengvall L.M., Johansson C., Scheynius A., Wahlgren C. Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients. Clin Exp Allergy. 30:2000;122-131
117. Schmidt M., Zargari A., Holt P., Lindbom L., Hellman U., Whitley P., et al. The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem. 246:1997;181-185
118. Yasueda H., Hashida-Okado T., Saito A., Uchida K., Kuroda M., Onishi Y., et al. Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur. Biochem Biophys Res Commun. 248:1998;240-244
119. Kim T.Y., Jang I.G., Park Y.M., Kim H.O., Kim C.W. Head and neck dermatitis: the role of Malassezia furfur, topical steroid use and environmental factors in its causation. Clin Exp Dermatol. 24:1999;226-231
120. Lindgren L., Wahlgren C.F., Johansson S.G., Wiklund I., Nordvall S.L. Occurrence and clinical features of sensitization to Pityrosporum orbiculare and other allergens in children with atopic dermatitis. Acta Derm Venereol. 75:1995;300-304
121. McGregor J.M., Hamilton A.J., Hay R.J. Possible mechanisms of immune modulation in chronic dermatophytoses: an in vitro study. Br J Dermatol. 127:1992;233-238
122. Rasool O., Zargari A., Almqvist J., Eshaghi H., Whitley P., Scheynius A. Cloning, characterization and expression of complete coding sequences of three IgE binding Malassezia furfur allergens, Mal f 7, Mal f 8 and Mal f 9. Eur J Biochem. 267:2000;4355-4361
123. Zargari A., Midgley G., Back O., Johansson S.G., Scheynius A. IgE-reactivity to seven Malassezia species. Allergy. 58:2003;306-311
124. Koyama T., Kanbe T., Ishiguro A., Kikuchi A., Tomita Y. Antigenic components of Malassezia species for immunoglobulin E antibodies in sera of patients with atopic dermatitis. J Dermatol Sci. 26:2001;201-208
125. Doekes G., Kaal M.J., van Ieperen-van Dijk A.G. Allergens of Pityrosporum ovale and Candida albicans. II. Physicochemical characterization. Allergy. 48:1993;401-408
126. Johansson S., Karlstrom K. IgE-binding components in Pityrosporum orbiculare identified by an immunoblotting technique. Acta Derm Venereol. 71:1991;11-16
127. Savolainen J., Lammintausta K., Kalimo K., Viander M. Candida albicans and atopic dermatitis. Clin Exp Allergy. 23:1993;332-339
128. Lintu P., Savolainen J., Kalimo K. IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients. Clin Exp Allergy. 27:1997;87-95
129. Wessels M.W., Doekes G., Van Ieperen-Van Kijk A.G., Koers W.J., Young E. IgE antibodies to Pityrosporum ovale in atopic dermatitis. Br J Dermatol. 125:1991;227-232
130. Zargari A., Harfast B., Johansson S., Johansson S.G., Scheynius A. Identification of allergen components of the opportunistic yeast Pityrosporum orbiculare by monoclonal antibodies. Allergy. 49:1994;50-56
131. Kanbe T., Koyama T. Atopic dermatitis and Malassezia species: a study of antigenic components Malassezia species for immunoglobulin E of patients with atopic dermatitis. Nippon Ishinkin Gakkai Zasshi. 44:2003;61-64
132. Cox H., Cookson W.O.C.M., Harper J. Genetic of atopic dermatitis. Harper J., Oranje A., Prose N. Pediatric dermatology. 2000;169-177 Blackwell Science, Oxford
133. Koyama T., Kanbe T., Ishiguro A., Kikuchi A., Tomita Y. Isolation and characterization of a major antigenic component of Malassezia globosa to IgE antibodies in sera of patients with atopic dermatitis. Microbiol Immunol. 44:2000;373-379
134. Abeck D., Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol. 139:1998;13-16
135. Brook I., Frazier E.H., Yeager J.K. Microbiology of infected atopic dermatitis. Int J Dermatol. 35:1996;791-793
136. Goh C.L., Wong J.S., Giam Y.C. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol. 36:1997;653-657
137. Klein P.A., Clark R.A.F., Nicol N.H. Acute infection with Trichophyton rubrum associated with flares of atopic dermatitis. Cutis. 63:1999;171-172
138. Skov L., Baadsgaard O. The potential role of Staphylococcus aureus superantigens in atopic eczema. J Eur Acad Dermatol Venereol. 7:1996;S8-S11
139. Lubbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol. 4:2003;641-654
140. Van de Kerkhof P.C., Franssen M.E. Psoriasis of the scalp: diagnosis and management. Am J Clin Dermatol. 2:2001;159-165
141. Rosenberg E.W., Belew P.W. Improvement of psoriasis of the scalp with ketoconazole. Arch Dermatol. 118:1982;370-371
142. Rosenberg E.W., Noah P.W., Skinner R.B. Jr., Vander Z.R., West S.K., Browder J.F. Microbial associations of 167 patients with psoriasis. Acta Derm Venereol Suppl (Stockh). 146:1989;72-74
143. Mayser P., Schutz M., Schuppe H.C., Jung A., Schill W.B. Frequency and spectrum of Malassezia yeasts in the area of the prepuce and glans penis. BJU Int. 88:2001;554-558
144. Ackerman A.B. Histopathologic differentiation of eczematous dermatitides from psoriasis and seborrheic dermatitis. Cutis. 20:1977;619-623
145. Baker B.S., Powles A., Garioch J.J., Hardman C., Fry L. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis. Br J Dermatol. 136:1997;319-325
146. Squiquera L., Galimberti R., Morelli L., Plotkin L., Milicich R., Kowalckzuk A., et al. Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clin Exp Dermatol. 19:1994;289-293
147. Kanda N., Tani K., Enomoto U., Nakai K., Watanabe S. The skin fungus-induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris. Clin Exp Allergy. 32:2002;1243-1250
148. Prohic A. Identification of Malassezia species isolated from scalp skin of patients with psoriasis and healthy subjects. Acta Dermatovenerol Croat. 11:2003;10-16
149. Gougerot H., Carteaud A. Papillomatose pigmentée innominée. Bull Soc Fr Dermatol Syph. 34:1927;719-721
150. Nordby C.A., Mitchell A.J. Confluent and reticulated papillomatosis responsive to selenium sulfide. Int J Dermatol. 25:1986;194-199
151. Yesudian P., Kamalam S., Razack A. Confluent and reticulated papillomatosis (Gougerot-Carteaud): an abnormal host reaction to Malassezia furfur. Acta Derm Venereol. 53:1973;381-384
152. Segal R., Alteras I., Sandbank M. Rapid response of transient acantholytic dermatosis to selenium sulfide treatment for pityriasis versicolor. Dermatologica. 175:1987;205-207
153. Crozier W.J., Wise K.A. Onychomycosis due to Pityrosporum. Australas J Dermatol. 34:1993;109-112
154. Silva V., Moreno G.A., Zaror L., de Oliveira E., Fischman O. Isolation of Malassezia furfur from patients with onychomycosis. J Med Vet Mycol. 35:1997;73-74
155. Kinnunen T., Koskela M. Antibacterial and antifungal properties of propylene glycol, hexylene glycol, and 1,3-butylene glycol in vitro. Acta Derm Venereol. 71:1991;148-150
156. McGinley K.J., Leyden J.J. Antifungal activity of dermatological shampoos. Arch Dermatol Res. 272:1982;339-342
157. Van Cutsem J., van Gerven F., Fransen J., Schrooten P., Janssen P.A. The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J Am Acad Dermatol. 22:1990;993-998
158. Warren R., Schwartz J.R., Sanders L.M., Juneja P.S. Attenuation of surfactant-induced interleukin-1alpha expression by zinc pyrithione. Exog Dermatol. 2:2003;23-27
159. Gupta A.K., Batra R., Bluhm R., Faergemann J. Pityriasis versicolor. Dermatol Clin. 21:2003;413-429
160. Gupta A.K., Bluhm R., Cooper E.A., Summerbell R.C., Batra R. Seborrheic dermatitis. Dermatol Clin. 21:2003;401-412
161. Uchida K., Nishiyama Y., Tanaka T., Yamaguchi H. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species. Int J Antimicrob Agents. 21:2003;234-238
162. Vardy D.A., Zvulunov A., Tchetov T., Biton A., Rosenman D. A double-blind, placebo-controlled trial of a ciclopirox olamine 1% shampoo for the treatment of scalp seborrheic dermatitis. J Dermatol Treat. 11:2000;73-77
163. Faergemann J., Hersle K., Nordin P. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Dermatology. 194:1997;19-21
164. Gupta A.K. Butenafine: an update of its use in superficial mycoses. Skin Therapy Lett. 7:2002;1-5
165. Ling M.R. Topical tacrolimus and pimecrolimus: future directions. Semin Cutan Med Surg. 20:2001;268-274
166. Nakagawa H., Etoh T., Yokota Y., Ikeda F., Hatano K., Teratani N., et al. Tacrolimus has antifungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis. Clin Drug Invest. 12:1996;245-250
167. Savin R.C. Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. J Am Acad Dermatol. 10:1984;824-830
168. Urcuyo F.G., Zaias N. The successful treatment of pityriasis versicolor by systemic ketoconazole. J Am Acad Dermatol. 6:1982;24-25
169. Ford G.P., Farr P.M., Ive F.A., Shuster S. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol. 111:1984;603-607
170. Ford G.P., Ive F.A., Midgley G. Pityrosporum folliculitis and ketoconazole. Br J Dermatol. 107:1982;691-695
171. Caputo R., Barbareschi M. Itraconazole: new horizons. G Ital Dermatol Venereol. 137:2002;1-7
172. Robertson L.I. Itraconazole in the treatment of widespread tinea versicolor. Clin Exp Dermatol. 12:1987;178-180
173. Rigopoulos D., Katsambas A., Antoniou C., Polydorou D., Vlachou M., Stratigos J. Tinea versicolor treated with fluconazole shampoo. Int J Dermatol. 31:1992;664-665
174. Rigopoulos D., Katsambas A., Antoniou C., Theocharis S., Stratigos J. Facial seborrheic dermatitis treated with fluconazole 2% shampoo. Int J Dermatol. 33:1994;136-137
175. Scaparro E., Quadri G., Virno G., Orifici C., Milani M. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial. Br J Dermatol. 144:2001;854-857
176. Faergemann J., Zehender H., Denouel J., Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Derm Venereol. 73:1993;305-309
177. Gupta A.K., Kohli Y., Li A., Faergemann J., Summerbell R.C. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol. 142:2000;758-765
178. Johnson B.A., Nunley J.R. Treatment of seborrheic dermatitis. Am Fam Physician. 61:2000;2703-2704
179. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol. 114:1986;695-700
180. Peter R.U., Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 132:1995;441-445
181. Faergemann J., Gupta A.K., Al Mofadi A., Abanami A., Shareaah A.A., Marynissen G. Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol. 138:2002;69-73
182. Faergemann J., Djarv L. Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis. 30:1982;542-550
183. Rausch L.J., Jacobs P.H. Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. Cutis. 34:1984;470-471